HPS-102 - Case report: Off-label use of magnesium sulfate for cerebral palsy prevention in preterm infants

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-102
• By: LIU, Chientzu (E-da Hospital, China Taiwan)
• Co-author(s): Ms Chientzu Liu (E-da Hospital, No. 1, Yida Rd., Yanchao Dist., Kaohsiung City, China Taiwan)
  Mr. YungJun Hung (E-da Hospital, No. 1, Yida Rd., Yanchao Dist., Kaohsiung City, China Taiwan)
  Mr. Yungchia Hsu (E-da Hospital, No. 1, Yida Rd., Yanchao Dist., Kaohsiung City, China Taiwan)
  
• Abstract:

  Introduction
  Magnesium sulfate (MgSO₄) is commonly used to treat hypomagnesemia and manage eclamptic seizures. Studies suggest fetal exposure to MgSO₄ before preterm birth may reduce cerebral palsy (CP) risk. Its neuroprotective mechanisms include cerebral blood flow stabilization, oxidative stress reduction, and anti-inflammatory effects...

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login